Bhaskar Agrochemicals Limited is a Hyderabad-based enterprise specializing in the **formulation of agrochemicals**. Established in **1988** and listed on the **BSE Limited**, the company operates as a single-segment entity dedicated to the production and sale of crop protection products. With a manufacturing base in Telangana and over five decades of promoter expertise, the company is currently navigating a strategic transition toward operational scaling and modernized financial management. --- ### **Core Infrastructure & Operational Footprint** The company’s operations are centralized within a single primary business segment: **Manufacturing and Sales of Agro Chemicals**. All production activities are consolidated at its primary facility to ensure oversight and quality control. | Feature | Details | | :--- | :--- | | **Primary Activity** | Manufacturing of **Agrochemical Formulations** | | **Manufacturing Facility** | **Toopranpet (V), Choutuppal (M)**, Yadadri Bhuvanagiri District, Telangana | | **Registered Office** | Madhapur, Hyderabad, Telangana | | **Quality Certifications** | **ISO 9001** (Quality), **ISO 14001** (Environment), and **ISO 45001** (Health & Safety) | | **Segment Reporting** | Single Operating Segment under **Ind AS - 108** | --- ### **Strategic Growth Drivers & Industry Outlook** Bhaskar Agrochemicals operates within an Indian agrochemical market valued at approximately **USD 36.5 billion** (FY 2024-25), growing at an annual rate of **10-12%**. The company is aligning its internal strategy with broader industry shifts: * **Technological Integration:** Adoption of **precision farming** tools, including **drones and satellite imagery**, alongside **AI-driven crop protection** and **IoT-enabled monitoring** to enhance utilization efficiencies. * **Product Diversification:** Increasing focus on **biopesticides**, which now constitute **15-18%** of the domestic market, to meet the rising demand for sustainable agricultural inputs. * **Supply Chain Resilience:** Strategic investment in the production of **off-patent molecules** to achieve **backward integration**, thereby reducing dependency on technical-grade imports from **China**. * **Government Tailwinds:** Leveraging rural demand stimulated by government initiatives such as **PM-Kisan**. --- ### **Financial Structure & Capital Management** The company has recently restructured its tax and capital frameworks to optimize its balance sheet and support a "going concern" status. **Taxation Strategy:** As of **May 2025**, the company transitioned to the **new tax provisions (22%)** under the Taxation Laws (Amendment) Ordinance, 2019. This followed a period of maintaining the old regime to exhaust **MAT Credit Entitlements**, which stood at **₹14.18 Lakhs** in 2024. **Capital and Shareholding (as of March 31, 2025):** * **Authorised Share Capital:** **Rs. 9.25 Crore** * **Paid-up Equity Capital:** **Rs. 5.21 Crore** (comprising 52,09,633 shares at **Rs. 10** par value). * **Preference Shares:** Under **Ind AS 32**, these are classified as **financial liabilities**. The company recently redeemed **1,85,000** shares (at **Rs. 100** par value, totaling **Rs. 1.85 Crore**), leaving **1,40,000** preference shares outstanding. **Liquidity and Debt Profile:** The company maintains a stable cash position of **Rs. 9.86 Lakhs** (March 2025). Funding is primarily sourced through **Axis Bank Limited**, secured by: * Hypothecation of all **current assets** and a first charge on assets created via term loans. * Equitable mortgage of **4.68 Acres** of industrial land and buildings at the **Toopranpet** site. * **Personal Guarantees** from the Managing Director, Joint Managing Director/CFO, and Director. * **Unsecured Loans** from Directors, which carry an interest rate of **12% per annum** and are repayable on demand. --- ### **Executive Leadership & Governance** To drive recovery and expansion, the company has revised its executive compensation structure effective **June 1, 2025**. This change reflects increased managerial responsibilities and aligns with industry standards for listed entities. | Position | Appointee | Monthly Remuneration | Performance Commission | Tenure | | :--- | :--- | :--- | :--- | :--- | | **Chairman & Managing Director** | Mr. P. Pattabhi Rama Rao | **Rs. 15,00,000** | Up to **5% of PAT** | Until **March 31, 2029** | | **Joint Managing Director** | Mr. P. Praveen Kumar | **Rs. 15,00,000** | Up to **5% of PAT** | Until **March 31, 2029** | The leadership relies on the **53 years of experience** of the Chairman to navigate intense sectoral competition and unfavorable market conditions. --- ### **Risk Management & Mitigation Framework** The company operates under a formal **Risk Management Policy** overseen by the Board, focusing on early identification of financial and operational volatility. **1. Market & Financial Risks:** * **Seasonality:** Business results vary significantly quarter-to-quarter based on **monsoon patterns** and sowing cycles. * **Interest Rate Risk:** Exposure to **floating rates** on long-term debt is managed through continuous monitoring of liquidity requirements. * **Currency Risk:** The company has **NIL exposure** to foreign currency risk, as all transactions are conducted in **Indian Rupees** within the domestic market. **2. Credit Risk Management:** The company employs a simplified **Expected Credit Loss (ECL)** model. Trade receivables stood at **Rs. 15.01 Crore** (March 2024) with an **ECL provision of Rs. 5.50 Lakhs**. **Receivables Aging Analysis (Historical Comparison in Thousands):** | Particulars | 31st March, 2023 | 31st March, 2022 | | :--- | :--- | :--- | | Not Due | **1,27,588.28** | **44,272.46** | | 0 - 180 Days | **10,664.01** | **55,477.39** | | 180 - 360 Days | **17,692.42** | **17,692.42** | | More than 360 Days | **11,758.91** | **0.00** | | **Total Exposure** | **1,67,703.62** | **1,17,442.28** | **3. Operational Controls:** * **Write-off Policy:** Receivables are written off if payments are more than **one year past due** with no expectation of recovery, though enforcement continues post-write-off. * **Internal Audit:** Regular **Systems Audits** evaluate the security and adequacy of control procedures, with findings reported directly to Senior Management for corrective action.